【膠原病・血管炎】 検査　自己抗体陽性は診断に直結しない
宮川 一平, 大坪 広樹, 真弓 俊彦
Intensivist, Oct. 2018, Reviewed, Null
Lead

【リウマチ・膠原病-病態に基づいた治療戦略】末梢血リンパ球サブセットによる病態解析と臨床応用
中山田 真吾, 宮川 一平, 久保 智史, 田中 良哉
カレントテラピー, May 2020, Reviewed, No invitation

【Immunology〜領域を超えた挑戦〜】RA領域　リウマチ医から見た乾癬性関節炎と生物学的製剤を用いたprecision medicine
宮川一平, 田中良哉
クリニシアン, Oct. 2018, Reviewed, No invitation
Lead

【リウマチ性疾患における分子標的療法の現在と未来-主に生物学的製剤を用いて-】脊椎関節炎
宮川 一平, 田中 良哉
リウマチ科, Jun. 2024, Reviewed, No invitation
Lead

末梢血T細胞フェノタイプによる乾癬性関節炎のprecision medicine
宮川 一平, 田中 良哉
リウマチ科, Dec. 2019, Reviewed, No invitation
Lead

乾癬性関節炎を合併した全身性エリテマトーデスに対してセクキヌマブが奏功した一例
藤田 悠哉, 中野 和久, 玉城 泰太郎, 吉成 紘子, 岩田 慈, 福與 俊介, 宮川 一平, 中山田 真吾, 田中 良哉
九州リウマチ, Mar. 2021, Reviewed, No invitation

強直性脊椎炎に対してTNF-α阻害薬で加療中に発症した掌蹠膿疱症の2症例
有冨 貴史, 中野 和久, 吉成 紘子, 中山田 真吾, 岩田 慈, 福與 俊介, 宮川 一平, 河邊 明男, 宮崎 佑介, 上野 匡庸, 田中 良哉
九州リウマチ, Mar. 2020, Reviewed, No invitation

無症候性IgG4関連胆嚢炎を伴ったIgG4関連疾患の一例
日下 勝秀, 中野 和久, 吉成 紘子, 岩田 慈, 福與 俊介, 花見 健太郎, 久保 智史, 宮川 一平, 河邊 明男, 宮崎 佑介, 名和田 彩, 井上 嘉乃, 上野 匡庸, 有冨 貴史, 中山田 真吾, 田中 良哉
九州リウマチ, Mar. 2019, Reviewed, No invitation

【自己免疫疾患　層別化する新時代へ　臨床検体のマルチオミクス解析、腸内細菌によって見えてきた免疫経路の全容】(第1章)精密医療を目指したマルチオミクス解析によるアプローチ　イムノフェノタイピングによる自己免疫疾患の層別化医療
田中 良哉, 宮川 一平, 久保 智史, 中山田 真吾
実験医学, Sep. 2022, Reviewed, No invitation

【脊椎関節炎の診断と治療update】乾癬性関節炎update　骨関節専門医の立場から
宮川 一平, 田中 良哉
整形・災害外科, Oct. 2024, Reviewed, No invitation
Lead

【乾癬性関節炎診療の最適化】乾癬性関節炎に対する生物学的製剤の使いわけ
宮川 一平, 田中 良哉
日本医事新報, Mar. 2019, Reviewed, No invitation
Lead

【血液浄化療法-持続的腎代替療法(CRRT)を中心に-】 エンドトキシン吸着カラム(PMX-DHP)は有用か?
真弓 俊彦, 首藤 瑠里, 椎野 明日実, 舛本 直哉, 岡本 直通, 佐藤 直人, 手嶋 悠人, 草永 真志, 秋本 倫太郎, 宮川 一平, 花石 源太郎, 弓指 恵一, 大坪 広樹
日本外科感染症学会雑誌, Jun. 2018, Reviewed, Null

【動脈・静脈の疾患2024(下)-最新の診断・治療動向-】血管炎　単一臓器血管炎
宮川 一平, 田中 良哉
日本臨床, Jul. 2024, Reviewed, No invitation
Lead

【膠原病診療の進歩2024-世界最新のガイドライン,リコメンデーション-】世界最新のガイドライン,リコメンデーション　乾癬性関節炎
宮川 一平, 田中 良哉
日本臨床, Aug. 2024, Reviewed, No invitation
Lead

【IgG4関連疾患-診断と治療の最近の考え方-】特論　開発中の治療
宮川 一平, 田中 良哉
日本臨床, Mar. 2024, Reviewed, No invitation
Lead

【混合性結合組織病(MCTD)-診断と治療の最近の考え方-】臨床　MCTDの特徴的な臨床症候,共通する症候
宮川一平, 田中良哉
日本臨床, Mar. 2023, Reviewed, No invitation
Lead

【乾癬性関節炎-診断と治療における最新知見-】治療　薬物療法　生物学的製剤の使い分け
中山田 真吾, 宮川 一平, 田中 良哉
日本臨床, Apr. 2021, Reviewed, No invitation

救急外来の自殺企図患者評価におけるSAD PERSONSスケールの有用性
岡本 直通, 宮川 一平, 濱田 信亮, 宮川 俊, 椎木 麻姫子, 成田 正雄, 石川 成人, 草永 真志, 吉村 玲児, 真弓 俊彦
日本臨床救急医学会雑誌, Aug. 2020, Reviewed, No invitation

【重症急性膵炎とその合併症に対するマネジメント】 重症急性膵炎の病態と重症化の機序
真弓 俊彦, 首藤 瑠里, 椎野 明日実, 舛本 直哉, 岡本 直通, 佐藤 直人, 手嶋 悠人, 草永 真志, 秋本 倫太郎, 宮川 一平, 花石 源太郎, 弓指 恵一, 大坪 広樹
消化器・肝臓内科, Jun. 2018, Not reviewed, No invitation

関節リウマチの鑑別診断(No.5)　乾癬性関節炎
宮川 一平, 田中 良哉
炎症と免疫, Feb. 2021, Reviewed, No invitation
Lead

乾癬性関節炎における末梢血ヘルパーT細胞フェノタイプに基づく生物学的製剤を用いたプレシジョン・メディシン
宮川一平, 中山田真吾, 中野和久
臨床のあゆみ, Feb. 2020, Reviewed, No invitation
Lead

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo Satoshi, Miyazaki Yusuke, Nishino Takahiro, Fujita Yuya, Kono Michihiro, Kawashima Tsugumi, Ishigaki Kazuyoshi, Kusaka Katsuhide, Tanaka Hiroaki, Ueno Masanobu, Satoh-Kanda Yurie, Inoue Yoshino, Todoroki Yasuyuki, Miyagawa Ippei, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Annals of the rheumatic diseases, Oct. 2024, Reviewed, No invitation

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo Satoshi, Miyazaki Yusuke, Nishino Takahiro, Fujita Yuya, Kono Michihiro, Kawashima Tsugumi, Ishigaki Kazuyoshi, Kusaka Katsuhide, Tanaka Hiroaki, Ueno Masanobu, Satoh-Kanda Yurie, Inoue Yoshino, Todoroki Yasuyuki, Miyagawa Ippei, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Annals of the rheumatic diseases, Feb. 2025, Reviewed, No invitation

Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching.
Kubo Satoshi, Nakayamada Shingo, Nakano Kazuhisa, Hirata Shintaro, Fukuyo Shunsuke, Miyagawa Ippei, Hanami Kentaro, Saito Kazuyoshi, Tanaka Yoshiya
Annals of the rheumatic diseases, Jul. 2016, Reviewed, Null

Peripheral immunophenotyping identifies three subgroups based on T cell heterogeneity in lupus patients.
Kubo Satoshi, Nakayamada Shingo, Yoshikawa Maiko, Miyazaki Yusuke, Sakata Kei, Nakano Kazuhisa, Hanami Kentaro, Iwata Shigeru, Miyagawa Ippei, Saito Kazuyoshi, Tanaka Yoshiya
Arthritis & rheumatology (Hoboken, N.J.), Jun. 2017, Reviewed, No invitation

Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study.
Miyagawa Ippei, Nakayamada Shingo, Ueno Masanobu, Miyazaki Yusuke, Iwata Shigeru, Kubo Satoshi, Sonomoto Koshiro, Anan Junpei, Ohkubo Naoaki, Inoue Yoshino, Tanaka Yoshiya
Arthritis research & therapy, Apr. 2022, Reviewed, No invitation
Lead

Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes.
Ueno Masanobu, Miyagawa Ippei, Miyazaki Yusuke, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Nakayamada Shingo, Tanaka Yoshiya
Arthritis research & therapy, Oct. 2022, Reviewed, No invitation

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
Masanobu Ueno, Ippei Miyagawa, Takafumi Aritomi, Koichi Kimura, Shigeru Iwata, Kentaro Hanami, Syunsuke Fukuyo, Satoshi Kubo, Yusuke Miyazaki, Shingo Nakayamada, Yoshiya Tanaka
Arthritis research & therapy, Jun. 2022, Reviewed, No invitation

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis.
Ueno Masanobu, Miyagawa Ippei, Nakano Kazuhisa, Iwata Shigeru, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Miyazaki Yusuke, Kawabe Akio, Yoshinari Hiroko, Nakayamada Shingo, Tanaka Yoshiya
Arthritis research & therapy, Mar. 2021, Reviewed, No invitation

Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study.
Miyazaki Yusuke, Nakano Kazuhisa, Nakayamada Shingo, Kubo Satoshi, Iwata Shigeru, Hanami Kentaro, Fukuyo Shunsuke, Miyagawa Ippei, Yamaguchi Ayako, Kawabe Akio, Saito Kazuyoshi, Tanaka Yoshiya
Arthritis research & therapy, Jun. 2021, Reviewed, No invitation

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation.
Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Ishikawa Yuichi, Yoshikawa Maiko, Sakata Kei, Iwata Shigeru, Miyagawa Ippei, Nakano Kazuhisa, Tanaka Yoshiya
Arthritis research & therapy, Jun. 2020, Reviewed, No invitation

Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease.
Miyagawa Ippei, Nakano Kazuhisa, Iwata Shigeru, Nakayamada Shingo, Saito Kazuyoshi, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Kawabe Akio, Miyazaki Yusuke, Tanaka Yoshiya
Arthritis research & therapy, Jun. 2019, Reviewed, No invitation
Lead

Regulatory mechanism of the induction of regulatory T cells through growth factors released by human mesenchymal stem cells.
Miyagawa I,Nakayamada S,Kondo M,Tanaka Y.
Critical reviews in immunology, Apr. 2018, Reviewed, No invitation
Lead

Optimal Biologic Selection for Treatment of Psoriatic Arthritis: the Approach to Precision Medicine.
Miyagawa Ippei, Nakayamada Shingo, Tanaka Yoshiya
Current rheumatology reports, Mar. 2019, Reviewed, No invitation
Lead

A wide perspective of targeted therapies for precision medicine in autoimmune diseases.
Miyagawa I, Kubo S, Tanaka Y.
Expert Review of Precision Medicine and Drug Development, Aug. 2020, Reviewed, No invitation
Lead

Is precision medicine possible in rheumatic diseases? Lessons from selective use of targeted therapies in patients with psoriatic arthritis.
Miyagawa Ippei, Tanaka Yoshiya
Expert review of clinical immunology, Feb. 2020, Reviewed, No invitation
Lead

Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis.
Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Nakano Kazuhisa, Iwata Shigeru, Miyagawa Ippei, Ma Xiaoxue, Trimova Gulzhan, Sakata Kei, Tanaka Yoshiya
Frontiers in immunology, Dec. 2018, Reviewed, No invitation

Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes.
Miyagawa Ippei, Nakayamada Shingo, Ueno Masanobu, Miyazaki Yusuke, Ohkubo Naoaki, Inoue Yoshino, Kubo Satoshi, Tanaka Yoshiya
Frontiers in medicine, Jul. 2022, Reviewed, No invitation
Lead

Dawn of Precision Medicine in Psoriatic Arthritis.
Miyagawa Ippei, Tanaka Yoshiya
Frontiers in medicine, Mar. 2022, Reviewed, No invitation
Lead

The approach to precision medicine for the treatment of psoriatic arthritis.
Miyagawa Ippei, Tanaka Yoshiya
Immunological medicine, Apr. 2020, Reviewed, No invitation
Lead

Mild encephalitis/encephalopathy with reversible splenial lesion in SLE.
Ohkubo N, Nakano K, Miyagawa I, Tanaka Y.
Internal Medicine, Feb. 2020, Reviewed, No invitation

Spontaneous Remission in a Patient with Anti-OJ Autoantibodies-positive Anti-synthetase Syndrome Following SARS-CoV-2 Infection and mRNA Vaccination: A Case Report.
Todoroki Yasuyuki, Nakayamada Shingo, Miyagawa Ippei, Kubo Satoshi, Yoshioka Kiyotake, Satoh Minoru, Tanaka Yoshiya
Internal medicine (Tokyo, Japan), Mar. 2025, Reviewed, No invitation

Five Cases of IgG4-related Disease with Nasal Mucosa and Sinus Involvement.
Ueno Masanobu, Nakano Kazuhisa, Miyagawa Ippei, Tanaka Yoshiya
Internal medicine (Tokyo, Japan), Apr. 2020, Reviewed, No invitation

An Autopsy Case with Cerebral Hemorrhaging due to disseminated Aspergillosis During Glucocorticoid Therapy for Overlap Syndrome of Systemic Lupus Erythematosus and Systemic Sclerosis.
Ueno Masanobu, Nakano Kazuhisa, Yoshinari Hiroko, Nakayamada Shingo, Iwata Shigeru, Kubo Satoshi, Miyagawa Ippei, Tanaka Yoshiya
Internal medicine (Tokyo, Japan), Apr. 2019, Reviewed, No invitation

The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
Miyagawa Ippei, Nakano Kazuhisa, Nakayamada Shingo, Iwata Shigeru, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Kawabe Akio, Miyazaki Yusuke, Inoue Yoshino, Ueno Masanobu, Ohkubo Naoaki, Fujita Yuya, Tanaka Yoshiya
International journal of rheumatic diseases, Feb. 2020, Reviewed, No invitation
Lead

Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.
Miyagawa Ippei, Nakano Kazuhisa, Nakayamada Shingo, Iwata Shigeru, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Inoue Yoshino, Ueno Masanobu, Tanaka Yoshiya
International journal of rheumatic diseases, Mar. 2019, Reviewed, No invitation
Lead

Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem Cells.
Miyagawa Ippei, Nakayamada Shingo, Nakano Kazuhisa, Yamagata Kaoru, Sakata Kei, Yamaoka Kunihiro, Tanaka Yoshiya
Journal of immunology (Baltimore, Md. : 1950), Sep. 2017, Reviewed, No invitation
Lead

Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.
Iwata S,Saito K,Hirata S,Ohkubo N,Nakayamada S,Nakano K,Hanami K,Kubo S, Miyagawa I,Yoshikawa M,Miyazaki Y,Yoshinari H,Tanaka Y.
Lupus, Apr. 2018, Reviewed, No invitation

A case of rheumatoid arthritis treated with infliximab who developed disseminated Penicillium marneffei infection after visit to Thailand.
Yoshinari H, Saito K, Nakano K, Fukuyo S, Miyagawa I, Tanaka Y.
Mod Rheumatol Case Reports, 2017, Reviewed, Null

The two cases of acute acalculous cholecystitis associated with systemic lupus erythematosus (SLE) presented different clinical aspects
Satoh Y, Nakano K, Miyazaki Y, Nakayamada S, Fukuyo S, Kubo S, Miyagawa I, Yoshinari H, Saito K, Satoh M, Tanaka Y
Modern Rheumatology Case Reports, Jan. 2019, Reviewed, No invitation

The abundance of regulatory T cell subsets is associated with the clinical outcomes of sarcoidosis.
Kusaka Katsuhide, Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Miyagawa Ippei, Satoh-Kanda Yurie, Todoroki Yasuyuki, Ueno Masanobu, Tanaka Yoshiya
Modern rheumatology, Apr. 2025, Reviewed, No invitation

Efficacy and Safety of High-Dose of Mycophenolate Mofetil Compared With Cyclophosphamide Pulse Therapy as Induction Therapy in Japanese Patients with Proliferative Lupus Nephritis.
Ohkubo Naoaki, Iwata Shigeru, Nakano Kazuhisa, Miyagawa Ippei, Hanami Kentaro, Fukuyo Shunsuke, Miyazaki Yusuke, Kawabe Akio, Nakayamada Shingo, Tanaka Yoshiya
Modern rheumatology, Oct. 2021, Reviewed, No invitation

Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
Nakano Kazuhisa, Saito Kazuyoshi, Nawata Aya, Hanami Kentaro, Kubo Satoshi, Miyagawa Ippei, Fujino Yoshihisa, Nakayamada Shingo, Tanaka Yoshiya
Modern rheumatology, Mar. 2020, Reviewed, No invitation

2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases.
Tanaka Yoshiya, Kuwana Masataka, Fujii Takao, Kameda Hideto, Muro Yoshinao, Fujio Keishi, Itoh Yasuhiko, Yasuoka Hidekata, Fukaya Shusaku, Ashihara Konomi, Hirano Daisuke, Ohmura Koichiro, Tabuchi Yuya, Hasegawa Hisanori, Matsumiya Ryo, Shirai Yuichiro, Ogura Takehisa, Tsuchida Yumi, Ogawa-Momohara Mariko, Narazaki Hidehiko, Inoue Yoshino, Miyagawa Ippei, Nakano Kazuhisa, Hirata Shintaro, Mori Masaaki
Modern rheumatology, Jan. 2020, Reviewed, No invitation

A case of newly onset rheumatoid arthritis successfully treated with methotrexate under the anti-retrovirus therapy against HIV infection.
Ippei Miyagawa,Shingo Nakayamada,Kazuyoshi Saito,Shoichi Shimizu,Kentaro Hanami,Masanobu Ueno,Yoshiya Tanaka
Modern rheumatology case reports, Feb. 2025, Null, Null
Lead

A case of Erdheim-Chester disease-a mimicker of IgG4-related disease and large vessel vasculitis.
Miyagawa Ippei, Nakayamada Shingo, Nohara Hirotsugu, Kosaka Shumpei, Ueno Masanobu, Tanaka Yoshiya
Modern rheumatology case reports, Dec. 2024, Reviewed, No invitation
Lead

An autopsy of a patient with polyarteritis nodosa who developed fatal intestinal perforation accompanied by systemic multiple aneurysms and arterial thrombosis.
Tsugita Nao, Miyagawa Ippei, Ueno Masanobu, Takahashi Miyabi, Kosaka Shumpei, Nakayamada Shingo, Tanaka Yoshiya
Modern rheumatology case reports, Dec. 2024, Reviewed, No invitation

Epstein-Barr virus-encoded RNA-positive lymphocytes in bone marrow and lymph nodes in an autopsy case of TAFRO syndrome.
Tsugita Nao, Miyagawa Ippei, Nakayamada Shingo, Nawata Aya, Kosaka Shumpei, Ueno Masanobu, Tanaka Yoshiya
Modern rheumatology case reports, Jan. 2025, Reviewed, No invitation

A case of glucocorticoid-resistant adult Still's disease complicated by pulmonary hypertension and interstitial lung disease.
Kusaka Katsuhide, Miyagawa Ippei, Kosaka Shunpei, Matsunaga Satsuki, Nakayamada Shingo, Tanaka Yoshiya
Modern rheumatology case reports, Jan. 2023, Reviewed, No invitation

A Patient with Eosinophilic Granulomatosis with Polyangiitis Successfully Weaned from Corticosteroids Through Remission Induction Therapy with Mepolizumab.
Ueno Masanobu, Miyagawa Ippei, Kawabe Akio, Kusaka Katsuhide, Nakayamada Shingo, Tanaka Yoshiya
Modern rheumatology case reports, Apr. 2022, Reviewed, No invitation

Systemic lupus erythematosus with repeated protein-losing enteropathy resulting from different pathological conditions: a case report.
Funada Masashi, Nakano Kazuhisa, Miyagawa Ippei, Ueno Masanobu, Tanaka Yoshiya
Modern rheumatology case reports, Jul. 2020, Reviewed, No invitation

A case of bone destruction caused by chronic non-bacterial osteomyelitis (CNO) successfully repaired with a tumour necrosis factor-α (TNF-α) inhibitor, adalimumab.
Kanda Ryuichiro, Nakano Kazuhisa, Miyagawa Ippei, Iwata Shigeru, Nakayamada Shingo, Tanaka Yoshiya
Modern rheumatology case reports, Jul. 2020, Reviewed, No invitation

An autopsy case of a patient with systemic sclerosis who developed marked pulmonary hypertension because of pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma.
Yamauchi Yusuke, Nakano Kazuhisa, Miyagawa Ippei, Inaba Yuna, Nawata Aya, Sato Naoko, Kumei Shinsuke, Kawanami Toshinori, Yatera Kazuhiro, Tanaka Yoshiya
Modern rheumatology case reports, Jan. 2020, Reviewed, No invitation

A case of systemic lupus erythematosus in which Cushing's syndrome caused by adrenal adenoma accidentally occurred during long-term maintenance therapy with corticosteroids.
Miyagawa Ippei, Nakano Kazuhisa, Nakayamada Shingo, Mori Hiroko, Okada Yosuke, Saito Kazuyoshi, Tanaka Yoshiya
Modern rheumatology case reports, Jan. 2020, Reviewed, No invitation
Lead

Blood DNA virome associates with autoimmune diseases and COVID-19.
SN, KS, KR, HT, NH, HT, WR, NY , OE, OK, YT, SK, YK, KT, SS, ER, SY, MY, NT, CS, TH, YH, SA, NK, AN, OT, NR, Namba S, NT, MI, TH, UM , IY, FJ, KK, I, FS, MH, MH, KM, MM, BT, NH, IT, HT, AA, MT, IK, NE, NI, Y-SM, YM, OS, KM, IS, AT, H M, TY, NT, IT, O S, HT, TT, TR, MK, TM, KS, SM, TK, NA, HT, TK, IH, IM, KT, TN, YK, MT, UA, IH, IK, GY, KH, FT, ST, YT, SY, IH, SM, ST, HN, NK , IS, TY, AY, SS, NC, JM, IH, AA, SH, KT, SS, KI, PHM, MTM, B AG, HK, OT, MH, IM, KR, KA, NE, SS, IH, FM, IY, YE, OS, KT, MA, MF, TM, KA, TY, OK, FK, IS, MS, PNF, OY
Nature genetics, Jan. 2025, Reviewed, No invitation

Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry.
Miyazaki Yusuke, Nakayamada Shingo, Tanaka Hiroaki, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Yamaguchi Ayako, Miyagawa Ippei, Satoh-Kanda Yurie, Todoroki Yasuyuki, Inoue Yoshino, Ueno Masanobu, Tanaka Yoshiya
RMD open, Jan. 2025, Reviewed, No invitation

Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus.
Ueno Masanobu, Iwata Shigeru, Yamagata Kaoru, Todoroki Yasuyuki, Sonomoto Koshiro, Nagayasu Atsushi, Miyagawa Ippei, Kubo Satoshi, Miyazaki Yusuke, Miyata Hiroko, Kanda Ryuichiro, Aritomi Takafumi, Nakayamada Shingo, Tanaka Yoshiya
RMD open, Dec. 2024, Reviewed, No invitation

CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry.
Funada Masashi, Miyazaki Yusuke, Nakayamada Shingo, Sonomoto Koshiro, Kubo Satoshi, Miyagawa Ippei, Tanaka Hiroaki, Tanaka Yoshiya
RMD open, Jun. 2024, Reviewed, No invitation

Efficacy, safety, and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.
Sakai Hidenori, Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Hanami Kentaro, Fukuyo Shunsuke, Yamaguchi Ayako, Miyagawa Ippei, Ueno Masanobu, Tanaka Hiroaki, Todoroki Yasuyuki, Ohkubo Naoaki, Funada Masashi, Matsunaga Satsuki, Tanaka Yoshiya
Rheumatology (Oxford, England), Sep. 2024, Reviewed, No invitation

Comparison of anti-IL-6 receptor and JAK inhibitors in patients with rheumatoid arthritis from the real-world practice FIRST study.
Miyazaki Yusuke, Nakayamada Shingo, Tanaka Hiroaki, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Todoroki Yasuyuki, Inoue Yoshino, Ueno Masanobu, Tanaka Yoshiya
Rheumatology (Oxford, England), Jun. 2024, Reviewed, No invitation

Safety and efficacy of anifrolumab therapy in systemic lupus erythematosus in real-world clinical practice: LOOPS registry.
Miyazaki Yusuke, Funada Masashi, Nakayamada Shingo, Sonomoto Koshiro, Tanaka Hiroaki, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Yamaguchi Ayako, Miyagawa Ippei, Todoroki Yasuyuki, Ueno Masanobu, Tanaka Yoshiya
Rheumatology (Oxford, England), Sep. 2024, Reviewed, No invitation

Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from FIRST registry.
Kubo Satoshi, Miyazaki Yusuke, Tanaka Hiroaki, Fujita Yuya, Sakai Hidenori, Ueno Masanobu, Todoroki Yasuyuki, Satoh-Kanda Yurie, Miyagawa Ippei, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology (Oxford, England), May 2025, Reviewed, No invitation

Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD.
Todoroki Yasuyuki, Kubo Satoshi, Nakano Kazuhisa, Miyazaki Yusuke, Ueno Masanobu, Satoh-Kanda Yurie, Kanda Ryuichiro, Miyagawa Ippei, Hanami Kentaro, Nakatsuka Keisuke, Saito Kazuyoshi, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology (Oxford, England), Mar. 2022, Reviewed, No invitation

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Kanda Ryuichiro, Miyazaki Yusuke, Nakayamada Shingo, Fukuyo Shunsuke, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Satoh-Kanda Yurie, Ohkubo Naoaki, Todoroki Yasuyuki, Tanaka Hiroaki, Ueno Masanobu, Nagayasu Atsushi, Fujita Yuya, Aritomi Takafumi, Kusaka Katsuhide, Sakai Hidenori, Matsunaga Satsuki, Nohara Hirotsugu, Tanaka Yoshiya
Rheumatology and therapy, Mar. 2025, Reviewed, No invitation

Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis.
Nagayasu Atsushi, Miyazaki Yusuke, Sonomoto Koshiro, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Tanaka Hiroaki, Todoroki Yasuyuki, Ueno Masanobu, Aritomi Takafumi, Fujita Yuya, Sakai Hidenori, Suzuki Katsunori, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology and therapy, Aug. 2025, Reviewed, No invitation

Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
Kubo Satoshi, Miyazaki Yusuke, Todoroki Yasuyuki, Nagayasu Atsushi, Kanda Ryuichiro, Aritomi Takafumi, Matsunaga Satsuki, Ueno Masanobu, Miyagawa Ippei, Sonomoto Koshiro, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology and therapy, Oct. 2023, Reviewed, No invitation

Lymphocyte phenotype and its application to precision medicine in systemic autoimmune diseases✰.
Tanaka Yoshiya, Kubo Satoshi, Miyagawa Ippei, Iwata Shigeru, Nakayamada Shingo
Seminars in arthritis and rheumatism, Jun. 2019, Reviewed, No invitation

Precision medicine using molecular-target drugs in psoriatic arthritis.
Miyagawa Ippei, Tanaka Yoshiya
Therapeutic advances in musculoskeletal disease, 2025, Reviewed, No invitation
Lead

Bimekizumab: a Humanized Monoclonal IgG1 Antibody for the Treatment of Psoriatic Arthritis.
Miyagawa I, Tanaka Y
touchREVIEWS in RMD, 2023, Reviewed, No invitation
Lead

Th22 cells promote osteoclast differentiation via production of IL-22.
Miyazaki Y,Nakayamada S,Kubo S,Nakano K,Iwata S,Miyagawa I,Ma X,Trimova G, Sakata K,Tanaka Y.
免疫Immunology Frontier, Apr. 2018, Reviewed, No invitation

乾癬性関節炎
宮川一平, 田中良哉, Contributor
先端医学社, May 2022, Reviewed
9784865505498